# Study of Two Dosages of Roaccutane in Cystic Acne

> **NCT07228481** · PHASE4 · COMPLETED · sponsor: **Premier Specialists, Australia** · enrollment: 91 (actual)

## Conditions studied

- Acne Cystic

## Interventions

- **DRUG:** isotretinoin (Roaccutane)
- **DRUG:** isotretinoin (Roaccutane)

## Key facts

- **NCT ID:** NCT07228481
- **Lead sponsor:** Premier Specialists, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06-26
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-05-10
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07228481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07228481, "Study of Two Dosages of Roaccutane in Cystic Acne". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07228481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*